Department of Internal Medicine, Niigata University Faculty of Medicine, Niigata.
Niigata College of Nursing, Joetsu, Japan.
J Hypertens. 2023 Mar 1;41(3):470-475. doi: 10.1097/HJH.0000000000003362. Epub 2023 Jan 12.
To investigate the combined effects of blood pressure (BP) and glycemic status on the risk of heart failure.
Examined was a Japanese claims database from 2008 to 2019 on 589 621 individuals. Cox proportional hazards model identified the incidence of heart failure among five levels of SBP/DBP according to glucose status.
Mean follow-up period was 5.6 years. The incidence of heart failure per 1000 person-years in the normoglycemia, borderline glycemia, and diabetes groups were 0.10, 0.18, and 0.80, respectively. In normoglycemia, a linear trend was observed between both SBP and DBP categories and hazard ratios for heart failure ( P for linearity <0.001). In borderline glycemia, J-shaped association was observed between DBP categories and hazard ratios, although the liner trend was significant ( P < 0.001). In diabetes, the linear trend for the relationship between DBP categories and hazard ratios was not significant ( P = 0.09) and the J-shaped association in relation to the hazard ratios was observed between SBP categories and heart failure risk. In the lowest SBP category (i.e. SBP < 120 mmHg), patients with diabetes had more than five-fold heart failure risk [hazard ratio (95% confidence interval), 5.10 (3.19-8.15)], compared with those with normoglycemia and SBP less than 120 mmHg.
The association between SBP/DBP and heart failure risk weakened with worsening of glucose metabolism, suggesting strict BP control accompanied by excessively lowered DBP should be cautious in prevent heart failure in abnormal glycemic status. Particularly in diabetes, comprehensive management of risk factors other than BP may be essential to prevent heart failure. Further trials are needed to support these suggestions and apply them to clinical practice.
探讨血压(BP)和血糖状态对心力衰竭风险的综合影响。
研究人员分析了 2008 年至 2019 年期间来自日本的一项理赔数据库,该数据库共纳入了 589621 例个体。采用 Cox 比例风险模型,根据血糖状态,确定了 5 个 SBP/DBP 水平下心力衰竭的发生率。
平均随访时间为 5.6 年。在血糖正常、边缘性高血糖和糖尿病组中,心力衰竭的发生率(每 1000 人年)分别为 0.10、0.18 和 0.80。在血糖正常组中,SBP 和 DBP 类别与心力衰竭的风险比之间存在线性趋势(线性趋势 P 值<0.001)。在边缘性高血糖组中,DBP 类别与风险比之间存在 J 型关联,尽管线性趋势显著(P<0.001)。在糖尿病组中,DBP 类别与风险比之间的线性趋势不显著(P=0.09),SBP 类别与心力衰竭风险之间存在 J 型关联。在最低 SBP 类别(即 SBP<120mmHg)中,与血糖正常且 SBP<120mmHg 的患者相比,糖尿病患者心力衰竭风险增加了五倍以上[风险比(95%置信区间)为 5.10(3.19-8.15)]。
SBP/DBP 与心力衰竭风险之间的关联随着葡萄糖代谢的恶化而减弱,这表明在异常血糖状态下,应谨慎控制血压,同时避免 DBP 过度降低。特别是在糖尿病患者中,除了血压以外,对其他危险因素进行综合管理可能对预防心力衰竭至关重要。需要进一步的临床试验来支持这些建议,并将其应用于临床实践。